2025 annual financial data
Acrivon Therapeutics 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -84,114,000 USD and net income was -77,905,000 USD.
Operating cash flow was -63,665,000 USD.
Get free Acrivon Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -84,114,000 USD
- Net income
- -77,905,000 USD
- Operating cash flow
- -63,665,000 USD